Crossmark

Wide-Antral pulmonary vein isolation in patients undergoing atrial fibrillation ablation with a Single-Shot technique: rationale and design of the WIDER-PVI trial

Crossref DOI link: https://doi.org/10.1007/s10840-025-02173-x

Published Online: 2025-11-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cobarro, Lucía https://orcid.org/0000-0003-3892-6338
Negreira-Caamaño, Martín https://orcid.org/0000-0002-7882-0469
Gómez-Burgueño, Lorena

López-Alacid, Isabel

Ramos-Jiménez, Javier https://orcid.org/0000-0002-5662-837X
Marco del Castillo, Álvaro https://orcid.org/0000-0002-5322-2067
Rajjoub Al-Mahdi, Ez Alddin https://orcid.org/0000-0003-0801-2156
Borrego-Bernabé, Luis

Estévez-Paniagua, Álvaro

Boveda, Serge https://orcid.org/0000-0002-1280-7042
Delgado, Juan https://orcid.org/0000-0002-5401-8324
Salguero-Bodes, Rafael https://orcid.org/0000-0003-1038-9710
Arribas-Ynsaurriaga, Fernando https://orcid.org/0000-0002-2574-7923
Rodríguez-Muñoz, Daniel https://orcid.org/0000-0003-3706-7092
License Information

Text and Data Mining valid from 2025-11-06

Version of Record valid from 2025-11-06
More Information

Article History

Received: 22 August 2025

Accepted: 23 October 2025

First Online: 6 November 2025

Declarations

:

: The authors declare no competing interests.

: DRM has received research grants and advisory/speaker honoraria from.

Document is current

Any future updates will be listed below